Avutometinib plus defactinib in recurrent low-grade serous ovarian cancer: A subgroup analysis of ENGOT-OV60/GOG-3052/ RAMP 201 Part A Meeting Abstract


Authors: Banerjee, S.; Van Nieuwenhuysen, E.; Santin, A.; Ring, K.; Colombo, N.; Thaker, P.; Prendergast, E.; Clamp, A.; Ray-Coquard, I.; Chon, H. S.; Moore, K.; Salinas, E.; Rose, P.; O'Malley, D.; Oaknin, A.; Monk, B.; Holloway, R.; Newman, G.; Moroney, J.; Van Gorp, T.; Kalbacher, E.; Gennigens, C.; Wojtynek, N.; Lustgarten, S.; Grisham, R.
Abstract Title: Avutometinib plus defactinib in recurrent low-grade serous ovarian cancer: A subgroup analysis of ENGOT-OV60/GOG-3052/ RAMP 201 Part A
Meeting Title: Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer
Journal Title: Gynecologic Oncology
Volume: 190
Issue: Suppl. 1
Meeting Dates: 2024 Mar 15-18
Meeting Location: San Deigo, CA
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 2024-11-01
Start Page: S55
End Page: S56
Language: English
ACCESSION: WOS:001330731400075
DOI: 10.1016/j.ygyno.2024.07.084
PROVIDER: wos
Notes: Meeting Abstract: 12 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rachel Nicole Grisham
    169 Grisham